pimozide has been researched along with Basal Ganglia Diseases in 20 studies
*Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (70.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, DE; Coughenour, LL; DeWald, HA; Lewis, EP; Lobbestael, SJ; Nordin, IC; Pattison, IC; Poschel, BP; Wise, LD | 1 |
| Baker, MA; Meyskens, FL; Neifeld, JP; Taub, RN; Tormey, DC | 1 |
| Campbell, M; Ernst, M; Gonzalez, NM | 1 |
| Dougherty, D; Sallee, FR; Sethuraman, G; Vrindavanam, N | 1 |
| Jackson, C; Nesbitt, L; Sallee, FR; Sethuraman, G; Sine, L | 1 |
| Bloch, M; Braun, A; Calis, KA; Grothe, DR; Rubinow, DR; Stager, S; Turcasso, NM | 1 |
| Aladag, A; Aydinli, M; Durmaz, Y; Korkut, M; Onal, C; Yakinci, C | 1 |
| Koo, J; Lee, CS | 1 |
| Obukhov, GA | 1 |
| Kuschinsky, K | 1 |
| Dingell, JV; Hill, H; Robinson, SE; Setler, P; Stawarz, RJ; Sulser, F | 1 |
| Garton, D; Silverstone, T | 1 |
| Anderson, AM; Chalmers, A; Heykants, JJ; McCreadie, RG | 1 |
| Alexander, PE; Bunney, WE; van Kammen, DP | 1 |
| Clark, ML; Costiloe, JP; Hill, D; Huber, WK; Wood, F | 1 |
| Marsden, CD; Pycock, C; Tarsy, D | 1 |
| Lang, AE | 1 |
| Claghorn, JL | 1 |
| Baro, F; Brugmans, J; Heykants, J | 1 |
| Glatzel, J | 1 |
8 trial(s) available for pimozide and Basal Ganglia Diseases
| Article | Year |
|---|---|
Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
Topics: Adolescent; Anti-Dyskinesia Agents; Basal Ganglia Diseases; Child; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Humans; Male; Pimozide; Prolactin; Tourette Syndrome | 1996 |
Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
Topics: Adolescent; Basal Ganglia Diseases; Child; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Patient Selection; Pimozide; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Tourette Syndrome; Treatment Outcome | 1997 |
Pimozide-induced depression in men who stutter.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Basal Ganglia Diseases; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Humans; Male; Middle Aged; Personality Inventory; Pimozide; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sex Factors; Speech; Stuttering | 1997 |
Pimozide in acute schizophrenia: a pilot study.
Topics: Acute Disease; Adult; Basal Ganglia Diseases; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pilot Projects; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1979 |
Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Calcium; Double-Blind Method; Female; Humans; Magnesium; Male; Pimozide; Schizophrenia; Time Factors | 1979 |
Pimozide in chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Consciousness Disorders; Drug Evaluation; Headache; Humans; Male; Middle Aged; Movement Disorders; Outpatient Clinics, Hospital; Pimozide; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Thioridazine | 1975 |
A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Antiparkinson Agents; Basal Ganglia Diseases; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Trifluoperazine | 1974 |
[Absorption, metabolism and excretion of pimozide in man].
Topics: Basal Ganglia Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Pimozide; Psychotic Disorders | 1972 |
12 other study(ies) available for pimozide and Basal Ganglia Diseases
| Article | Year |
|---|---|
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profiles.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Catalepsy; Corpus Striatum; Haloperidol; Humans; In Vitro Techniques; Male; Mice; Motor Activity; Piperazines; Piperidines; Rats; Receptors, Dopamine; Self Stimulation; Structure-Activity Relationship | 1985 |
Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients.
Topics: Adult; Aged; Basal Ganglia Diseases; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pimozide; Skin Neoplasms | 1983 |
Acute dystonic reaction with low-dose pimozide.
Topics: Autistic Disorder; Basal Ganglia; Basal Ganglia Diseases; Child; Dystonia; Humans; Male; Pimozide | 1993 |
Cavernous hemangioma in a child presenting with hemichorea: response to pimozide.
Topics: Basal Ganglia Diseases; Brain Neoplasms; Caudate Nucleus; Child; Chorea; Diagnosis, Differential; Dominance, Cerebral; Hemangioma, Cavernous; Humans; Magnetic Resonance Imaging; Male; Neurologic Examination; Pimozide; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Delusions; Diagnosis, Differential; Electrocardiography; Female; Humans; Male; Middle Aged; Parasitic Diseases; Pimozide; Quality of Life | 2001 |
[Prolonged action neuroleptics (review of the foreign literature)].
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Child; Chronic Disease; Delayed-Action Preparations; Dibenzazepines; Dibenzothiepins; Dosage Forms; Drug Therapy, Combination; Fluphenazine; Humans; Paranoid Disorders; Perphenazine; Pimozide; Piperazines; Piperidines; Schizophrenia; Structure-Activity Relationship; Thioridazine; Thioxanthenes; Tranquilizing Agents | 1975 |
[Cellular effect of neuroleptics].
Topics: Adenylyl Cyclases; Basal Ganglia Diseases; Biological Transport, Active; Catecholamines; Chlorpromazine; Dopamine; Dopamine Antagonists; Histamine H1 Antagonists; Humans; Norepinephrine; Pimozide; Receptors, Drug; Reserpine; Schizophrenia; Serotonin Antagonists; Tranquilizing Agents | 1975 |
On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Clozapine; Corpus Striatum; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Homovanillic Acid; Humans; Limbic System; Male; Phenylacetates; Pimozide; Rats; Receptors, Drug; Rotation; Stereotyped Behavior; Substantia Nigra; Thioridazine | 1975 |
Plasma pimozide profiles in chronic schizophrenics.
Topics: Basal Ganglia Diseases; Chronic Disease; Half-Life; Humans; Male; Pimozide; Schizophrenia; Time Factors | 1979 |
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior; Biogenic Amines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Chlorpromazine; Clozapine; Corpus Striatum; Dextroamphetamine; Diazepam; Dopamine; Haloperidol; Humans; Hydroxydopamines; Levodopa; Male; Metoclopramide; Mice; Motor Activity; Pentobarbital; Phenoxybenzamine; Pimozide; Promethazine; Stereotyped Behavior; Tranquilizing Agents | 1975 |
Persistent hemiballismus with lesions outside the subthalamic nucleus.
Topics: Aged; Basal Ganglia Diseases; Corpus Striatum; Humans; Male; Middle Aged; Movement Disorders; Pimozide; Tomography, X-Ray Computed; Valproic Acid | 1985 |
[Clinical and statistical evaluation of neuroleptic pimozide].
Topics: Adult; Aged; Basal Ganglia Diseases; Chronic Disease; Female; Humans; Male; Middle Aged; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Statistics as Topic | 1971 |